
Along with Kris V. Kowdley, MD, FACP, FACG, FASGE, AGAF, choose management strategies for a patient with chronic hepatitis B receiving treatment with adefovir.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Summarize data showing the relationship between early responses to oral anti–hepatitis B virus agents and future treatment outcomes
- Discuss the importance of Week 12 and 24 virologic monitoring in making on-treatment decisions for hepatitis B in patients receiving oral therapy
- Recount the on-treatment definitions of response in hepatitis B and differential management strategies based on treatment response